preliminary results from phase i study of cd123 car-t therapy in pediatric r/r aml
Published 1 year ago • 237 plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
7:20
kpm | ams alliance| icinac series | acidification analyzer | anchrom
-
3:42
further analysis of quantum-first: the impact of allo-hct combined with quizartinib in flt3-itd aml
-
41:36
webinar: pgs total solution
-
0:43
imr-90 transfection kit
-
![[tctap 2023] clinical science - all about new data from amc](https://i.ytimg.com/vi/NZdvw4VUCnw/mqdefault.jpg)
1:16:36
[tctap 2023] clinical science - all about new data from amc
-
15:21
elizabeth wong - conversion of effector cd4 t cells to an mhcii-restricted cd8 lineage
-
![novel dnaaf2 variants cause pcd - supplementary video 1 [id 338981]](https://i.ytimg.com/vi/hrYJHqtmaYs/mqdefault.jpg)
0:05
novel dnaaf2 variants cause pcd - supplementary video 1 [id 338981]
-
14:23
progress report ii - caroline kelly
-
![[introductory session] ich](https://i.ytimg.com/vi/vRuP1KivTBE/mqdefault.jpg)
14:18
[introductory session] ich
-
13:31
progress report ii - éva mlinkó
-
13:12
progress report i - mohammed altenni
-
3:00
simplify™ irt
-
1:50
progress for gilteritinib and quizartinib for aml in the first-line setting
-
2:03
discover our counting data management software solution
-
14:02
progress report ii - adolf lichtfusz
-
11:51
progress report i - eszter hoffmann
-
2:06
fighting cancer through early detection
-
25:11
ending ms progression webcast